Volume | 28,117,338 |
|
|||||
News | - | ||||||
Day High | 11.07 | Low High |
|||||
Day Low | 9.475 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
Advisorshares Pure Us Cannabis Etf | MSOS | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
11.05 | 9.475 | 11.07 | 9.57 | 11.26 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
100,920 | 28,117,338 | 10.02 | 281,831,888 | - | 4.78 - 11.365 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
19:00:00 | 867,588 | 9.57 | USD |
Advisorshares Pure Us Ca... (MSOS) Options Flow Summary
Advisorshares Pure Us Cannabis Etf Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.13B | - | - | - | 12.38 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Advisorshares Pure Us Ca...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MSOS Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.78 | 11.365 | 8.32 | 10.21 | 17,411,158 | 0.88 | 10.02% |
1 Month | 10.14 | 11.365 | 8.32 | 9.73 | 11,961,119 | -0.48 | -4.73% |
3 Months | 10.28 | 11.365 | 7.30 | 9.34 | 9,366,776 | -0.62 | -6.03% |
6 Months | 5.60 | 11.365 | 5.32 | 8.64 | 7,531,438 | 4.06 | 72.50% |
1 Year | 5.52 | 11.365 | 4.78 | 7.89 | 6,315,616 | 4.14 | 75.00% |
3 Years | 43.15 | 44.14 | 4.78 | 10.63 | 3,091,525 | -33.49 | -77.61% |
5 Years | 24.90 | 55.91 | 4.78 | 12.07 | 2,639,797 | -15.24 | -61.20% |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified. |